Medx Health Corp

TSXV:MDXCanadaView on OTC Pink - Current Information

Oct 23, 2024

Show headlines and story abstract

• MedX Health Corp. announces Amended Application for Series I Loan Note Extension, from 10:24AM ET on Wednesday Oct 23, 2024 by Dow Jones

  10:24AM ET on Wednesday Oct 23, 2024 by Dow Jones
  Companies Mentioned: MDX
  
  MedX Health Corp. announces Amended Application for Series I Loan Note Extension
  MISSISSAUGA, Ontario--(BUSINESS WIRE)--October 23, 2024--
  MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announces that further to its Press Release dated August 6, 2024, the TSXV issued a Final Acceptance Letter dated August 14, 2024, in respect of the Amendment to the remaining outstanding $3,700,000 of the Series I Loan Notes issued in 2021, by the Extension of the Maturity Date from December 31, 2023, to December 31, 2025, but has since withdrawn that Final Acceptance. The Company is now filing an application for a revised Final Acceptance of the Extension of the Maturity Date for the Series I Loan Notes, only in respect of $2,650,000 of Series I Loan Notes in respect of which Extension Agreements have been signed. In the event that any of the holders of Series I Loan Notes who have not yet signed Extension Agreements do decide to accept the Extension, then the Company may submit request(s) to the TSXV for Acceptance, issuance of which will be subject to applicable TSXV Policies.